Stay updated on Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial

Sign up to get notified when there's something new on the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    - Added Revision: v3.5.0 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-19T19:47:25.000Z thumbnail image
  4. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T02:34:28.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The only change observed is a revision update on the page from v3.4.0 to v3.4.1, with no alteration to study details, eligibility criteria, outcomes, locations or other user-visible content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T00:26:17.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Glossary display is now shown and new metadata items were added: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while the previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T22:15:53.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added the new revision tag: Revision: v3.3.4. Removed the previous tag: Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T06:36:53.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Added a centralized 'Locations' section listing all study sites by state/province (e.g., Alabama, Arizona, Alberta, Ontario, etc.). Individual location subsections were replaced by this consolidated list.
    Difference
    1%
    Check dated 2025-12-23T21:33:53.000Z thumbnail image

Stay in the know with updates to Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page.